12 . 07 . 2018

Cincinnati Children’s Hospital joins the Xplore-2 trial


Cincinnati Children’s Hospital joins the Xplore-2 trial

Cincinnati Children’s Hospital has joined other prominent U.S. pediatric centers in the Xplore-2 FDA-approved clinical research study, the first medical center in the Midwest to take part in the trial. The medical institutions already enrolling patients as part of the Xplore-2 trial include: Boston Children’s Hospital, Children’s Healthcare of Atlanta, Children’s Hospital Los Angeles, Chil...

Scroll inside box for more news
The Children’s Hospital Colorado joins the Xplore-2 trial
5 . 07 . 2018

The Children’s Hospital Colorado joins the Xplore-2 trial

The Children’s Hospital of Pittsburgh of UPMC joins the Xplore-2 trial
25 . 06 . 2018

The Children’s Hospital of Pittsburgh of UPMC joins the Xplore-2 trial

Children’s Hospital Los Angeles joins the Xplore-2 Study
22 . 06 . 2018

Children’s Hospital Los Angeles joins the Xplore-2 Study

Xeltis restorative technology for aortic valves at ISMICS
13 . 06 . 2018

Xeltis restorative technology for aortic valves at ISMICS

Preliminary Xplore-1 data show promise at ECHSA
1 . 06 . 2018

Preliminary Xplore-1 data show promise at ECHSA

Preliminary Xplore-1 data at ECHSA
30 . 05 . 2018

Preliminary Xplore-1 data at ECHSA

Xeltis’ aortic valve program in focus at EuroPCR
22 . 05 . 2018

Xeltis’ aortic valve program in focus at EuroPCR

Xeltis’ restorative technology at ICTEHV
14 . 05 . 2018

Xeltis’ restorative technology at ICTEHV

Xeltis selected as finalist for Swiss Medtech Awards
2 . 05 . 2018

Xeltis selected as finalist for Swiss Medtech Awards

Fun and sports for children with CHD
19 . 04 . 2018

Fun and sports for children with CHD

Xeltis CEO wins Global Business Excellence Award for Outstanding Executive
17 . 04 . 2018

Xeltis CEO wins Global Business Excellence Award for Outstanding Executive

Xeltis’ restorative aortic valves show promise at HVS
13 . 04 . 2018

Xeltis’ restorative aortic valves show promise at HVS

Xeltis CEO on late-stage financing at Medtech Strategist Summit
12 . 04 . 2018

Xeltis CEO on late-stage financing at Medtech Strategist Summit

Xeltis nominated for the Swiss Medtech Award
11 . 04 . 2018

Xeltis nominated for the Swiss Medtech Award

Xeltis pays tribute to Arnaud de Ménibus
10 . 04 . 2018

Xeltis pays tribute to Arnaud de Ménibus

Xeltis’ restorative aortic valves at HVS
6 . 04 . 2018

Xeltis’ restorative aortic valves at HVS

Xeltis CEO on leading start-ups to success at START Summit
16 . 03 . 2018

Xeltis CEO on leading start-ups to success at START Summit

Prof. Carrel brings Xeltis’ restorative heart valves to ACC 2018
12 . 03 . 2018

Prof. Carrel brings Xeltis’ restorative heart valves to ACC 2018

Xeltis’ innovation in the spotlight at CRT2018
2 . 03 . 2018

Xeltis’ innovation in the spotlight at CRT2018

Xeltis joining forces on HVD Awareness Day
22 . 02 . 2018

Xeltis joining forces on HVD Awareness Day

Xeltis is in Swiss Venture Capital Report
1 . 02 . 2018

Xeltis is in Swiss Venture Capital Report

Webinar outlines new horizons for pulmonary heart valve therapy
30 . 01 . 2018

Webinar outlines new horizons for pulmonary heart valve therapy

Webinar: A future without reoperations?
26 . 01 . 2018

Webinar: A future without reoperations?

The Xplore-2 feasibility study under way in the US
26 . 01 . 2018

The Xplore-2 feasibility study under way in the US

Preclinical Data on Xeltis’ Pulmonary Valve Published in <em>JTCVS</em>
16 . 01 . 2018

Preclinical Data on Xeltis’ Pulmonary Valve Published in JTCVS

Our corporate Christmas gift this year…
19 . 12 . 2017

Our corporate Christmas gift this year…

Preclinical data on Xeltis’ Aortic Valve published in <em>EuroIntervention</em>
5 . 12 . 2017

Preclinical data on Xeltis’ Aortic Valve published in EuroIntervention

Xeltis CFO speaks at Swiss IPO event
29 . 11 . 2017

Xeltis CFO speaks at Swiss IPO event

Xeltis and Dutch Noord-Brabant Province meet to boost regional cooperation
17 . 11 . 2017

Xeltis and Dutch Noord-Brabant Province meet to boost regional cooperation

Xeltis Closes €45 Million Series C Financing
15 . 11 . 2017

Xeltis Closes €45 Million Series C Financing

Positive Preclinical Data on Xeltis Pulmonary Valve to be published in <i>Eurointervention</i>
8 . 11 . 2017

Positive Preclinical Data on Xeltis Pulmonary Valve to be published in Eurointervention

Xeltis’ Aortic Valve preclinical results shared at TCT 2017
1 . 11 . 2017

Xeltis’ Aortic Valve preclinical results shared at TCT 2017

TCT 2017 to feature restorative heart valve therapy discussion
30 . 10 . 2017

TCT 2017 to feature restorative heart valve therapy discussion

Xeltis’ Preclinical Aortic Valve Data at PCR London Valves
26 . 09 . 2017

Xeltis’ Preclinical Aortic Valve Data at PCR London Valves

ETR featured in peer-reviewed journal EuroIntervention
25 . 09 . 2017

ETR featured in peer-reviewed journal EuroIntervention

Laurent Grandidier to speak at UBS Disruptive Technology Summit
25 . 09 . 2017

Laurent Grandidier to speak at UBS Disruptive Technology Summit

Xeltis CTO on the future of heart valve therapy at PCR London Valves
22 . 09 . 2017

Xeltis CTO on the future of heart valve therapy at PCR London Valves

Positive progression of ETR clinical trials at WCPCCS
20 . 07 . 2017

Positive progression of ETR clinical trials at WCPCCS

Patients inspire the Xeltis Team
7 . 07 . 2017

Patients inspire the Xeltis Team

7 Vidi grants reward Xeltis’ long-standing academic research partner
16 . 06 . 2017

7 Vidi grants reward Xeltis’ long-standing academic research partner

Xeltis’ RestoreX technology to be presented at TVT 2017
14 . 06 . 2017

Xeltis’ RestoreX technology to be presented at TVT 2017

Excellent Preclinical Performance of Restorative Aortic Valve
10 . 06 . 2017

Excellent Preclinical Performance of Restorative Aortic Valve

Excellent preclinical data show RestoreX potential for restorative vascular treatment
6 . 06 . 2017

Excellent preclinical data show RestoreX potential for restorative vascular treatment

Xeltis’ restorative heart valve therapy featured at EuroPCR
17 . 05 . 2017

Xeltis’ restorative heart valve therapy featured at EuroPCR

EuroPCR to host first ETR dedicated plenary session
15 . 05 . 2017

EuroPCR to host first ETR dedicated plenary session

Xeltis CTO at Biomedica Summit
8 . 05 . 2017

Xeltis CTO at Biomedica Summit

Professor Lange joins Xeltis’ Medical Advisory Board
2 . 05 . 2017

Professor Lange joins Xeltis’ Medical Advisory Board

Xeltis wins Gold Edison Award in medical technology
21 . 04 . 2017

Xeltis wins Gold Edison Award in medical technology

Potential of new cardiovascular restoration strategies presented at SFB
5 . 04 . 2017

Potential of new cardiovascular restoration strategies presented at SFB

Xeltis data on cardiovascular restoration with electrospun polymers at SFB
4 . 04 . 2017

Xeltis data on cardiovascular restoration with electrospun polymers at SFB

Xeltis shortlisted for Company of the Year
15 . 03 . 2017

Xeltis shortlisted for Company of the Year

<em>Science TM on ETR</em>: “Biology and engineering integrated at staggering level”
7 . 03 . 2017

Science TM on ETR: “Biology and engineering integrated at staggering level”

Preclinical heart valve restoration study in Biomaterials
3 . 03 . 2017

Preclinical heart valve restoration study in Biomaterials

Positive two-year preclinical data on Xeltis’ PV at HVS meeting
2 . 03 . 2017

Positive two-year preclinical data on Xeltis’ PV at HVS meeting

Xeltis clinical data published in JTCVS
24 . 02 . 2017

Xeltis clinical data published in JTCVS

“Xeltis has the potential to redefine heart valve replacement therapy”
21 . 02 . 2017

“Xeltis has the potential to redefine heart valve replacement therapy”

Leading cardiologist to present Xeltis’ bioabsorbable valve at CRT 2017
19 . 02 . 2017

Leading cardiologist to present Xeltis’ bioabsorbable valve at CRT 2017

Xeltis CTO’s entrepreneurial perspective at Innovation for Healthcare
14 . 02 . 2017

Xeltis CTO’s entrepreneurial perspective at Innovation for Healthcare

Xeltis is a 2017 Edison Awards Finalist
9 . 02 . 2017

Xeltis is a 2017 Edison Awards Finalist

“How to build a successful med-tech company”
8 . 02 . 2017

“How to build a successful med-tech company”

FDA gives Xeltis go ahead to begin trials in the USA
31 . 01 . 2017

FDA gives Xeltis go ahead to begin trials in the USA

Season’s Greetings: A Word from the CEO
23 . 12 . 2016

Season’s Greetings: A Word from the CEO

Introducing the RestoreX brand
21 . 12 . 2016

Introducing the RestoreX brand

Xeltis completes patient enrollment in Xplore-I trial
19 . 12 . 2016

Xeltis completes patient enrollment in Xplore-I trial

Xeltis receives nomination for 2017 Edison Awards
14 . 12 . 2016

Xeltis receives nomination for 2017 Edison Awards

Xeltis expands Clinical Advisory Board’s expertise with significant EU and US appointments
22 . 11 . 2016

Xeltis expands Clinical Advisory Board’s expertise with significant EU and US appointments

Xeltis announces multidisciplinary Scientific Advisory Board of global leading experts
1 . 11 . 2016

Xeltis announces multidisciplinary Scientific Advisory Board of global leading experts

Xeltis to introduce aortic valve program at TCT 2016 New Technology Forum
28 . 10 . 2016

Xeltis to introduce aortic valve program at TCT 2016 New Technology Forum

Three patients successfully implanted with Xeltis’ bioabsorbable pulmonary valve in Asia
21 . 10 . 2016

Three patients successfully implanted with Xeltis’ bioabsorbable pulmonary valve in Asia

Xeltis two steps closer to redefining heart valve replacement: highlights from EACTS 2016
10 . 10 . 2016

Xeltis two steps closer to redefining heart valve replacement: highlights from EACTS 2016

Two-year clinical data show positive functionality of Xeltis’ bioabsorbable cardiovascular device
5 . 10 . 2016

Two-year clinical data show positive functionality of Xeltis’ bioabsorbable cardiovascular device

First Heart Valve Enabling Heart Restoration Successfully Implanted
2 . 10 . 2016

First Heart Valve Enabling Heart Restoration Successfully Implanted

Xeltis data set to make an impact at EACTS 2016
1 . 10 . 2016

Xeltis data set to make an impact at EACTS 2016

Excitement builds about Xeltis’ potential from MedTech Strategist front cover
30 . 09 . 2016

Excitement builds about Xeltis’ potential from MedTech Strategist front cover

Leading cardiovascular experts join Xeltis Clinical Advisory Board
19 . 09 . 2016

Leading cardiovascular experts join Xeltis Clinical Advisory Board

Xeltis technology enables cardiovascular regeneration in high blood pressure, preclinical data showed at ISACB
9 . 09 . 2016

Xeltis technology enables cardiovascular regeneration in high blood pressure, preclinical data showed at ISACB

Martijn Cox: Bringing Xeltis technology to life
7 . 09 . 2016

Martijn Cox: Bringing Xeltis technology to life

Xeltis awarded extended ISO certification
8 . 07 . 2016

Xeltis awarded extended ISO certification

Xeltis joins launch of Dutch Regenerative Medicine institute
7 . 07 . 2016

Xeltis joins launch of Dutch Regenerative Medicine institute

Xeltis Celebrates 10th Anniversary
1 . 07 . 2016

Xeltis Celebrates 10th Anniversary

Meet the Xeltis team at Eindhoven Expat Fair
10 . 06 . 2016

Meet the Xeltis team at Eindhoven Expat Fair

Xeltis in-vivo data demonstrating Endogenous Tissue Restoration presented at WBC
21 . 05 . 2016

Xeltis in-vivo data demonstrating Endogenous Tissue Restoration presented at WBC

Xeltis late-breaking data at AATS set stage for the development of first bioabsorbable heart valve
17 . 05 . 2016

Xeltis late-breaking data at AATS set stage for the development of first bioabsorbable heart valve

Xeltis pulmonary valve on track for 2016 clinical trials – stated CEO at PCR Innovators Day
16 . 05 . 2016

Xeltis pulmonary valve on track for 2016 clinical trials – stated CEO at PCR Innovators Day

Xeltis bioabsorbable cardiovascular technology clinical data are late breaker at AATS
12 . 05 . 2016

Xeltis bioabsorbable cardiovascular technology clinical data are late breaker at AATS

Renowned start-up advocate met with Xeltis co-founder
10 . 05 . 2016

Renowned start-up advocate met with Xeltis co-founder

Laurent Grandidier in the 2016 Medicine Maker Power List 100
29 . 04 . 2016

Laurent Grandidier in the 2016 Medicine Maker Power List 100

Xeltis selected to present at EuroPCR Innovators Day
15 . 04 . 2016

Xeltis selected to present at EuroPCR Innovators Day

Innovation in MedTech invites Xeltis CEO back to present
14 . 04 . 2016

Innovation in MedTech invites Xeltis CEO back to present

US FDA granted Humanitarian Use Device for Xeltis pulmonary valve
23 . 03 . 2016

US FDA granted Humanitarian Use Device for Xeltis pulmonary valve

Xeltis pulmonary conduit data presented at HVS
17 . 03 . 2016

Xeltis pulmonary conduit data presented at HVS

Xeltis to present to leading investors at European forum
15 . 03 . 2016

Xeltis to present to leading investors at European forum

Xeltis CEO to present at leading BioCapital event
3 . 03 . 2016

Xeltis CEO to present at leading BioCapital event

Heart Awareness Month
24 . 02 . 2016

Heart Awareness Month

Xeltis’ QMS received ISO certification
18 . 02 . 2016

Xeltis’ QMS received ISO certification

Supporting CHD Awareness Week 2016
11 . 02 . 2016

Supporting CHD Awareness Week 2016

Xeltis appoints new CFO
2 . 02 . 2016

Xeltis appoints new CFO

Dutch figurehead Professor Jan Raaijmakers visits Xeltis
29 . 01 . 2016

Dutch figurehead Professor Jan Raaijmakers visits Xeltis

Leading Research Program NRP 63 featuring Xeltis’ technology
28 . 01 . 2016

Leading Research Program NRP 63 featuring Xeltis’ technology

How Xeltis overcame medtech financial challenges
22 . 01 . 2016

How Xeltis overcame medtech financial challenges

Xeltis-led research published in Tissue Engineering Part A
6 . 01 . 2016

Xeltis-led research published in Tissue Engineering Part A

Xeltis extends series B financing to €30M, signing off transformational year
17 . 12 . 2015

Xeltis extends series B financing to €30M, signing off transformational year

Nobel Laureate Professor Lehn visiting Xeltis
9 . 12 . 2015

Nobel Laureate Professor Lehn visiting Xeltis

Xeltis CEO Laurent Grandidier receives Award for Best CEO in Medical Devices
5 . 12 . 2015

Xeltis CEO Laurent Grandidier receives Award for Best CEO in Medical Devices

Xeltis nominates Michel Darnaud as new Chairman
19 . 11 . 2015

Xeltis nominates Michel Darnaud as new Chairman

The positive economics of the Xeltis technology
17 . 11 . 2015

The positive economics of the Xeltis technology

Xeltis completed second feasibility clinical trial on novel bioabsorbable cardiovascular device technology
10 . 11 . 2015

Xeltis completed second feasibility clinical trial on novel bioabsorbable cardiovascular device technology

Eliane Schutte joins the Xeltis Executive Team as Chief Development Officer
5 . 11 . 2015

Eliane Schutte joins the Xeltis Executive Team as Chief Development Officer

First ever bioabsorbable heart conduit by Xeltis implanted two years ago
23 . 10 . 2015

First ever bioabsorbable heart conduit by Xeltis implanted two years ago

Xeltis-led research on supramolecular polymer bioabsorbtion in Acta Biomaterialia
23 . 10 . 2015

Xeltis-led research on supramolecular polymer bioabsorbtion in Acta Biomaterialia

A heart-racing day for Heartbeat Foundation
19 . 10 . 2015

A heart-racing day for Heartbeat Foundation

Xeltis one of 15 most promising private medtech companies globally
14 . 10 . 2015

Xeltis one of 15 most promising private medtech companies globally

Martijn Cox on Xeltis research in Brabants Dagblad
30 . 09 . 2015

Martijn Cox on Xeltis research in Brabants Dagblad

Xeltis at Les Journées de Moscou, L’Obs’s Moscow Forum
24 . 09 . 2015

Xeltis at Les Journées de Moscou, L’Obs’s Moscow Forum

Xeltis proudly presents short movie of its first charity event
13 . 08 . 2015

Xeltis proudly presents short movie of its first charity event

Omroep Brabant portrays Xeltis in a video reportage
4 . 08 . 2015

Omroep Brabant portrays Xeltis in a video reportage

Cooperation is essential: Xeltis appeared in renowned Netherlands Heart Journal June issue
9 . 07 . 2015

Cooperation is essential: Xeltis appeared in renowned Netherlands Heart Journal June issue

Xeltis completes first study of Endogenous Tissue Restoration technology
19 . 05 . 2015

Xeltis completes first study of Endogenous Tissue Restoration technology

Xeltis nominates Michel Darnaud for election to its Board of Directors
18 . 05 . 2015

Xeltis nominates Michel Darnaud for election to its Board of Directors

Xeltis presenting on PCR Innovators day
11 . 05 . 2015

Xeltis presenting on PCR Innovators day

Xeltis’ CEO Laurent Grandidier meets Willem-Alexander, King of the Netherlands
28 . 04 . 2015

Xeltis’ CEO Laurent Grandidier meets Willem-Alexander, King of the Netherlands

Financieele Dagblad portrays Xeltis and its Dutch-Swiss culture
9 . 03 . 2015

Financieele Dagblad portrays Xeltis and its Dutch-Swiss culture

Le Temps writes about revolutionary approaches in heart surgery
17 . 02 . 2015

Le Temps writes about revolutionary approaches in heart surgery

Successful Start-Ups in the Netherlands: Xeltis is mentioned in Link Magazine
17 . 02 . 2015

Successful Start-Ups in the Netherlands: Xeltis is mentioned in Link Magazine

Xeltis welcomes Boris Warnack as a new member of the Executive Team
1 . 02 . 2015

Xeltis welcomes Boris Warnack as a new member of the Executive Team

Four million Euro to develop new vascular graft for kidney dialysis
19 . 01 . 2015

Four million Euro to develop new vascular graft for kidney dialysis

Xeltis’ investment round in Biotech Finances
12 . 12 . 2014

Xeltis’ investment round in Biotech Finances

Eindhovens Dagblad writes about Xeltis’ Series B financing
11 . 12 . 2014

Eindhovens Dagblad writes about Xeltis’ Series B financing

Xeltis closes EURO 27 million / USD 34 million series B Financing
2 . 12 . 2014

Xeltis closes EURO 27 million / USD 34 million series B Financing

Xeltis featured by Dutch television program
7 . 11 . 2014

Xeltis featured by Dutch television program

Dutch Minister of Finance visits Xeltis
4 . 11 . 2014

Dutch Minister of Finance visits Xeltis

Professor Schoen on supramolecular chemistry in Cardiology Today
3 . 06 . 2014

Professor Schoen on supramolecular chemistry in Cardiology Today

Xeltis’ recent article in Cardiology Today:
19 . 05 . 2014

Xeltis’ recent article in Cardiology Today:

Xeltis on the frontpage of News Medical
26 . 03 . 2014

Xeltis on the frontpage of News Medical

MDD leads with Xeltis story
12 . 03 . 2014

MDD leads with Xeltis story

Xeltis Completes Enrolment in World’s First Study of Spontaneous Tissue Growth
22 . 02 . 2014

Xeltis Completes Enrolment in World’s First Study of Spontaneous Tissue Growth

Xeltis Appoints Nobel Prize Winner  Prof. Jean-Marie Lehn To Its Advisory Board
7 . 01 . 2014

Xeltis Appoints Nobel Prize Winner Prof. Jean-Marie Lehn To Its Advisory Board

6 . 01 . 2014

6 . 01 . 2014

New CFO joins Xeltis’ awesome team
21 . 11 . 2013

New CFO joins Xeltis’ awesome team

Innovation in a changing medtech landscape
5 . 11 . 2013

Innovation in a changing medtech landscape

Xeltis CEO speaks at Life Science Week
9 . 10 . 2013

Xeltis CEO speaks at Life Science Week

Eindhoven – The world’s most inventive city
19 . 08 . 2013

Eindhoven – The world’s most inventive city

Xeltis wins ‘Next Gem Award in Medtech’
2 . 04 . 2013

Xeltis wins ‘Next Gem Award in Medtech’

Xeltis Team wishes all seasons greetings
5 . 03 . 2013

Xeltis Team wishes all seasons greetings

Xeltis selected as Hot Pick of the Month and featured in Clinica
8 . 02 . 2013

Xeltis selected as Hot Pick of the Month and featured in Clinica

Xeltis Director of R&D chosen to represent “innovation”
7 . 02 . 2013

Xeltis Director of R&D chosen to represent “innovation”

Xeltis re-launches website
5 . 02 . 2013

Xeltis re-launches website

Xeltis CEO Laurent Grandidier presents at two prestigious conferences
5 . 02 . 2013

Xeltis CEO Laurent Grandidier presents at two prestigious conferences

Xeltis 25 European medtech startups
5 . 02 . 2013

Xeltis 25 European medtech startups

Latest Tweets

Scroll inside box for more tweets

Latest Tweets

LinkedIn Posts

Scroll inside box for more posts

    LinkedIn Company Updates

  • 1 Day Agoview on linkedin

    Xeltis

    Proud to support today’s @Mended Little Hearts CHD symposium which provides guidance and advice for families living with CHDs. Mended Little Hearts helps with a range of resources including educational webinars https://lnkd.in/ecBtRCN

  • 2 Days Agoview on linkedin

    Xeltis

    The New York Times shares a significant development in restorative heart therapy in 'Dying Organs Restored to Life in Novel Experiments' Congratulations to Boston Children's Hospital and all those involved https://lnkd.in/efD-TGY

  • 3 Days Agoview on linkedin

    Xeltis

    Cincinnati Children’s Hospital is the first Midwest-based center joining the FDA-approved Xplore-2 research study evaluating Xeltis’ novel restorative pulmonary heart valve for Right Ventricular Outflow Tract (RVOT) reconstruction. https://xplore2trial.com/

  • 3 Days Agoview on linkedin

    Xeltis

    FDA-approved clinical research on pulmonary heart valve replacement for patients that need #RVOT reconstruction is ongoing in U.S. pediatric centers. To learn more please visit www.xplore2trial.com

  • 10 Days Agoview on linkedin

    Xeltis

    The Children’s Hospital Colorado is the first center in the Mountain States joining the Xplore-2 trial, an FDA-approved research study investigating Xeltis’ novel restorative pulmonary heart valve for Right Ventricular Outflow Tract (RVOT) reconstruction. https://xplore2trial.com/